Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Invested Capital (2016 - 2025)

Haemonetics (HAE) has 16 years of Return on Invested Capital data on record, last reported at 0.09% in Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 3.0% year-over-year to 0.09%; the TTM value through Dec 2025 reached 0.09%, down 3.0%, while the annual FY2025 figure was 0.1%, 1.0% down from the prior year.
  • Return on Invested Capital reached 0.09% in Q4 2025 per HAE's latest filing, up from 0.09% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.15% in Q3 2023 and bottomed at 0.06% in Q2 2022.
  • Average Return on Invested Capital over 5 years is 0.1%, with a median of 0.1% recorded in 2022.
  • Peak YoY movement for Return on Invested Capital: fell -11bps in 2021, then increased 8bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.08% in 2021, then increased by 24bps to 0.09% in 2022, then grew by 8bps to 0.1% in 2023, then grew by 16bps to 0.12% in 2024, then fell by -23bps to 0.09% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.09% in Q4 2025, 0.09% in Q3 2025, and 0.09% in Q2 2025.